TransThera Sciences (Nanjing), Inc. (02617)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chui Hoi Yam | 17-Oct-22 | INED, MbCC, ChNC, MbStrC | |||
| Cui Songxi | 02-Aug-21 | VP | |||
| Fan Jing | 01-Nov-22 | CMedO, COO | |||
| Feng Jie | 02-Aug-21 | BrdSec, J-CoSec | |||
| Feng Weibo | 18-Jun-26 | INED, ChCC, MbAC, MbNC | |||
| Jia Zhongxin | 11-Sep-18 | NED, MbAC, MbCC, MbStrC | |||
| Li Shupai | 17-Jun-21 | INED, ChAC | |||
| Mei Jianghua | 16-Mar-20 | Sup | |||
| Pang Yajing | 16-Jul-21 | Sup | |||
| Peng Peng | 17-Jun-21 | VP | |||
| Sheng Zejuan | 02-Aug-21 | VP | |||
| Sun Caixia | 02-Aug-21 | ED | |||
| Wong Tik | 23-Jun-25 | J-CoSec, AuRep | |||
| Wu Di | 16-Mar-20 | ED | |||
| Wu Di | 16-Mar-20 | ED, VP, FC, AuRep | |||
| Wu Frank | 10-May-16 | ED, Ch, CEO, MbNC, ChStrC | |||
| Zhao Weili | 17-Jun-21 | ChSup | |||
| Zheng Zhelan | 17-Oct-22 | 18-Jun-26 | INED | Ms. Zheng no longer serves upon the conclusion of the AGM. | |
| 17-Oct-22 | 31-Mar-26 | INED, MbAC, ChCC, MbNC | Personal work arrangements. | ||
| Yi Hua | 16-Mar-20 | 31-Mar-26 | NED | Considering the arrangement of relevant affairs of the shareholders he represents and his personal work arrangement. His decision to resign is based on his own work commitment and is not related to the Company. |